Your browser doesn't support javascript.
loading
Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
Heitmeier, Stefan; Visser, Mayken; Tersteegen, Adrian; Dietze-Torres, Julia; Glunz, Julia; Gerdes, Christoph; Laux, Volker; Stampfuss, Jan; Roehrig, Susanne.
Affiliation
  • Heitmeier S; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Visser M; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Tersteegen A; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Dietze-Torres J; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Glunz J; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Gerdes C; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Laux V; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Stampfuss J; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
  • Roehrig S; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
J Thromb Haemost ; 20(6): 1400-1411, 2022 06.
Article in En | MEDLINE | ID: mdl-35289054
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Factor XIa Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Factor XIa Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom